07.2025
Built for discovery
Operon™ is GATC Health’s proprietary, AI-powered discovery engine, where predictive intelligence meets collaborative innovation.
Multiomic data integration enables Operon to simulate the full complexity of human biology, predicting a drug candidate’s efficacy, safety, and success rates up to 11x better than industry averages – before clinical testing even begins.
Explore Platform Capabilities:
Drug discovery timelines that span months, not years
Together with GATC Health’s decades of drug discovery and development expertise, the Operon engine provides an objective, pragmatic view of drug candidates, helping teams collaborate more closely than ever to devise strategy and pressure-test results for faster delivery of innovative therapies.
4-6 months
18-24 months
36-48 months
GATC Health MAT Platform
4-6 months
AI Assisted
18-24 months
Traditional
36-48 months
GATC Health MAT Platform
Development in 4-6 months
Development in 4-6 Months
GATC’s Health MAT platform simulates biology end-to-end and delivers 3–5 optimized compounds ready for preclinical testing in record time, while other methods are still in discovery
AI Assisted
Development in 18-24 months
Development in 18-24 Months
GATC’s Operon platform simulates biology end-to-end and delivers 3–5 optimized compounds ready for preclinical testing in record time, while other methods still in discovery
Traditional
Development in 36-48 months
Development in 36-48 Months
GATC’s Operon platform simulates biology end-to-end and delivers 3–5 optimized compounds ready for preclinical testing in record time, while other methods still in discovery
Real speed. Real results. Real impact.
Operon is more than just a platform. It’s a comprehensive process and partnership model that dramatically accelerates drug discovery and development – from uncovering novel drug IP and repurposing shelved candidates to extending indications and optimizing clinical development.
96%
savings
in pre-clinical cost
Less than $5 million, compared to industry average of $140 million
2-5
years faster
pre-clinical phase
10-18 months to reach trial phase
80%
success
rate or greater
10-18 months to reach trial phase
The definitive AI report for predictive risk intelligence
Powered by Operon, the Derisq™ AI Report by GATC Health delivers objective, AI-powered insights that help biotech leaders and investors prioritize assets and predict outcomes – all before committing capital or entering the clinic.
Building your next breakthrough, together
Partner with people who put your science and success first. Uniting the industry’s experts in AI, biology, drug development, and business, GATC Health is ready to help you get to work on what’s next.
